IMMUNOGLOBULINS AND LIPID PROFILE OF CHILDREN WITH SICKLE CELL ANEMIA IN EKITI STATE, NIGERIA

Oyeyemi A O; Oyebanji O G

doi:10.22159/ajpcr.2018.v11i9.25503

Authors

Oyeyemi A O Department of Biochemistry, Ekiti State University, Ekiti State, Nigeria.
Oyebanji O G Department of Biochemistry, Ekiti State University, Ekiti State, Nigeria.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i9.25503

Keywords:

Immunoglobins, Lipid profile, Sickle cell anemia

Abstract

Objective: Sickle cell disease (SCD) is a hereditary blood disorder characterized by an abnormality in the oxygen-carrying hemoglobin and associated with some acute and chronic health problems such as severe infections, severe pain (sickle cell crisis), and stroke. The aim of this study was to evaluate the levels of immunoglobulins (Ig) and the lipid profile in children with SCD in Ekiti state, Nigeria.

Methods: Samples of 200 children (120 sickle celled and 80 healthy children) between the ages of 1â€“8 years old were collected from Ekiti State University Teaching Hospital, Ado Ekiti and Federal Medical Centre, Ido Ekiti, Ekiti State, Nigeria. Plasma Ig (IgM and IgG) and lipid profile (total cholesterol [TC], high-density lipoprotein [HDL], low-density lipoprotein (LDL), very LDL (VLDL), and triacylglycerol [TG]) were evaluated in patients' blood sample using standard established methods. The results obtained were subjected to statistical analysis (P<0.05).

Results: Sickle-celled children showed a significant reduction in the levels of Ig (IgM and IgG). Furthermore, TC, LDL-C, VLDL-C, and TG showed significant higher value whereas high-density lipoprotein cholesterol was significantly reduced in sickle-celled patients compared with nonsickle-celled patients.

Conclusion: It is understood that sickle cell is detrimental to immunoglobins and metabolic profile. These biochemical makers determined were implicated in children with sickle cell anemia.

Downloads

Download data is not yet available.

Author Biographies

Oyeyemi A O, Department of Biochemistry, Ekiti State University, Ekiti State, Nigeria.

Senior Lecturer

Department of Biochemistry,

Ekiti State University,

Ado Ekiti, Ekiti State Nigeria

Oyebanji O G, Department of Biochemistry, Ekiti State University, Ekiti State, Nigeria.

Assistant lecturer

Department of Biochemistry,

Ekiti State University,

Ado Ekiti, Ekiti State Nigeria

References

Oyeyemi AO, Sonuga AA, Oyebanji OG. Comparism of antioxidants status among children, teenagers and adults with sickle cell anaemia. Intern J Eng Sci Invent 2017;6 Suppl 7:18-21.

Kathleen AN, Julie AP. Pharmacotherapy of sickle cell disease. 18th Expert Committee on the Selection and Use of Essential Medicines; 2011. p. 1-16.

American Academy of Pediatrics. Policy statement. Health supervision for children with sickle cell disease. Pediatrics 2002;109:526-35.

Nagababu E, Fabry ME, Nagel RL, Rifkind JM. Heme degradation and oxidative stress in murine models for hemoglobinopathies: Thalassemia, sickle cell disease and hemoglobin C disease. Blood Cells Mol Dis 2008;41 Suppl 1:6066.

Quinm CT, Rogers ZR, Mccavit TL, Buchanan, GR. Improved survival of children and adolescent with sickle cell disease. Blood 2004;115:3447-52.

Oyeyemi AO, Oyebanji OG, Akinlua I. Evaluation of antioxidant enzymes in children with sickle cell anaemia in Ekiti state, Nigeria. J Med Dent Sci Res 2016;3 Suppl 7:1-4.

Abdullah UY, Jassim HM, Baig AA, Khorsheed RM, Al-Khayat AM, Sulong AF, et al. Gallstones in patients with inherited hemolytic diseases. Int J Pharm Pharm Sci 2015;7:9-15.

Goldsby RA, Kindt TJ, Osborne BA, Kuby J. Immunology. New York: W.H Freeman and Company; 2003. p. 5.

Gotto AM. Triglyceride: The forgotten risk factor. Circulation 1998;97:1027-8.

Abdel-Reheim ES. Cardioprotective efficacy of taurine on lipid-metabolism of isoproterenol-induced myocardial infarction. Int J Pharm Pharm Sci 2016;8:135-40.

Malvano R, Rook GA, Jannuzzi C, Voller A. Enzyme-linked immunosorbent assay for quantitation of toxoplasma antibodies in human sera. J Clin Pathol 1981;53:635-7.

Trinder P. Report of the national cholesterol educational program. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med 1988;148:36-9.

Lopes-Virella MF. HDL - Cholesterol precipitant. Chemestry 1977;23:882-5.

Fredrerickson-Friedewald WT. Method for the determination of LDL-cholesterol. Clin Chem 1972;18:499-502.

Zar JH. Biostatistical Analysis. 2nd ed. Upper Saddle River, NJ: Prentice Hall Inc.; 1984. p. 106.

Ballas SK, Burka ER, Lewis CN, Krasnow SH. Serum immunoglobulin levels in patients having sickle cell syndromes. Am J Clin Pathol 1980;73 Suppl 3:394-6.

Dieye TN, Ndiaye O, Ndiaye AB, Thiam D, Fall-Seck K, Diop S, et al. Complement and serum immunoglobulins in homozygous and heterozygous sickle cell anemia in Senegal. Dakar Med 1999;44 Suppl 2:175-9.

Alassane D, Fatou C, Fatou GT, Fatou D, Oumar TF, NdÃ©nÃ© SG, et al. Serum lipids and oxidized low density lipoprotein levels in sickle cell disease: Assessment and patho biological significance. Afr J Biochem Res 2014;8 Suppl 2:39-42.

Magda OS, Larissa CR, Mauricio BC, Joelma FM, Isa ML, Valma ML, et al. Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease. Lipids Health Dis 2010;9:91.

da Luz PL, Favarato D, Faria-Neto JR, Lemos P, Chagas AC. High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics 2008;64:427-32.

Mukherjee MB, Gangakhedkar RR. Physical growth of children with sickle cell disease. Indian J Hum Genet 2004;10 Suppl 2:70-2.